fbpx

 

Multiple Sclerosis Society of Canada  – Webinar Registration

 

MS 101: LIVE PANEL SESSION 

November 2, 2021  6:30PM ET  (1.5 hours)

3:30PM  PT

VICTORIA, BC

4:30 MT

EDMONTON, AB

REGINA, SK

 

 

5:30PM CT

WINNIPEG, MB

6:30PM ET

TORONTO, ON

7:00PM AT

HALIFAX, NS

7:30PM NT

ST.JOHN’S, NL

Having as much information as possible will enable you to make the best treatment decisions for your unique MS journey. On Nov 2, placeholder will discuss ….

Sarah Donkers

Sarah Donkers, PT, PhD

 

Sarah is a physiotherapist and Assistant Professor in the College of Medicine, University of Saskatchewan. Sarah’s area of research focuses on maximizing function for people with neurological conditions. Her PhD investigated the use of behaviour change strategies for physical activity promotion in neurological conditions, with an emphasis on targeting physical activity behaviour in the routine management of MS. Sarah continues to explore ways to apply behavioural science to maximizing neurorecovery. Sarah is a PI for the Cameco MS Neuroscience Research Centre. Her primary goal at the moment is to improve access to and quality of rehabilitation services for individuals living with MS in Canada. 

Nancy Bogle

Nancy Bogle, RN, BSN

 

Nancy Bogle graduated from the BSN Nursing program at UBC after completing her BA at Acadia University in Wolfville, Nova Scotia. Aside from a short stint exploring Community Health and Pediatric Neurology work, most of her career has focused on Multiple Sclerosis. Nancy first came to the UBC Clinic in 1995 and was involved in the initiation of the Special Therapies Program for the first approved disease modifying therapies in MS. In late 1996, Nancy moved to the area of MS Research at the UBC Clinic and has since remained there with the occasional day spent in the UBC MS Clinic. Nancy is a published author of a paper on Psychological Determinants as a factor to Coping with MS, a co-author of an article for Nursing specialization in MS for the International MS Order of Nurses, a previous presenter at a plenary session of The Canadian Neurological Nurses Association and has presented posters at the MS Consortium in 2000. She also presented a poster “Alemtuzumab Infusion Management: The British Columbia Experience” at ECTRIMS 2015. Nancy considers the ability to work with persons and their families with MS a great privilege

Denise Kendrick

Denise Kendrick, OT

Denise Kendrick is an Occupational Therapist employed by Vancouver Coastal Health and a Clinical Instructor in the Department of Occupational Science and Occupational Therapy. She has a particular interest in gerontology and participates as a tutor for students in the Department of Occupational Science and Occupational Therapy. Her research work examines the efficacy of self-management in chronic mild acquired brain injury.

Dr. Placeholder

Placeholder is professor of medicine in the field of neurology at the University of Ottawa, director of the Multiple Sclerosis Research Unit at the Ottawa Hospital, and a Senior Scientist at the Ottawa Hospital Research Institute.

They have published over 250 pieces, including scientific articles, books, book chapters and abstracts and has delivered hundreds of lectures and presentations nationally and internationally.

 

Placeholder has over 25 years of experience in the management of patients with multiple sclerosis and has been the principal investigator on numerous clinical trials with new therapeutic agents for MS.

Please note, this webinar will be conducted in English only.

 

MSSC Disclaimer: The MS Society does not approve, endorse, or recommend any specific product or therapy but provides information to assist individuals in making their own decisions.

 

If you have any questions please call Laurie Murphy at 306-994-6652 toll free: 1-800-268-7582, or email at: Laurie.Murphy@mssociety.ca

 

Each person must register individually, Google Chrome is recommended for the best registration and attendance experience.

For the day of the webinar you must use Google Chrome or Firefox web browser.  Mobile devices such as phones or tablets are supported if they are running Android or Apple IOS.

Sponsored by: